Dren Bio, Inc. announced it raised $25.5 Million in an amended filing from an offering of $60 Million

Nov 12, 2020•about 5 years ago

Amount Raised

$25.5 Million

Foster CityBiotechnology

Company Information

Company

DR-0201

Location

321 GRUNION COURT

Foster City, California, United States

About

DR-0201 is a targeted bispecific myeloid cell engager. It is designed for deep B-cell depletion, particularly in immunology applications. This therapy represents a potential treatment option for diseases like lupus. The acquisition strengthens Sanofi's early pipeline.

Related People

1 contact

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Dren Bio, Inc. announced it raised $25.5 Million in an amended filing from an offering of $60 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information